{"id":7589,"date":"2023-06-12T17:19:17","date_gmt":"2023-06-12T21:19:17","guid":{"rendered":"https:\/\/www.millerthomson.com\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/"},"modified":"2024-09-12T15:26:30","modified_gmt":"2024-09-12T19:26:30","slug":"zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover","status":"publish","type":"deals-cases","link":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","title":{"rendered":"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e"},"content":{"rendered":"<p>Le 6\u00a0juin 2023, ZYUS Life Sciences Inc. (\u00ab\u00a0ZYUS\u00a0\u00bb), une entreprise priv\u00e9e canadienne sp\u00e9cialis\u00e9e en sciences de la vie, et Phoenix Canada Oil Company Limited (TSX-V:PCO) (la \u00ab\u00a0soci\u00e9t\u00e9\u00a0\u00bb) ont annonc\u00e9 la cl\u00f4ture d\u2019un financement par re\u00e7us de souscription avec interm\u00e9diaire pour un produit total brut d\u2019environ 20?130?131\u00a0$ \u00e0 la suite de l\u2019\u00e9mission de 12?581?332\u00a0re\u00e7us de souscription de ZYUS au prix de 1,60\u00a0$ chacun.<\/p>\n<p>Le 12\u00a0juin 2023, ZYUS et la soci\u00e9t\u00e9 ont annonc\u00e9 avoir compl\u00e9t\u00e9 la prise de contr\u00f4le invers\u00e9e pr\u00e9c\u00e9demment annonc\u00e9e conform\u00e9ment aux conditions d\u2019une convention d\u2019arrangement dat\u00e9e du 15\u00a0novembre 2022 (dans sa version modifi\u00e9e) (la \u00ab\u00a0convention d\u2019arrangement\u00a0\u00bb) en vertu de laquelle ZYUS et la soci\u00e9t\u00e9 ont r\u00e9alis\u00e9 un regroupement d\u2019entreprises par le biais d\u2019un plan d\u2019arrangement.<\/p>\n<p>Le financement a \u00e9t\u00e9 dirig\u00e9 par Stifel Nicolaus Canada Inc., Haywood Securities Inc. et Roth Canada Inc. qui ont agi \u00e0 titre de co-chefs de file et de teneurs de livres associ\u00e9s.<\/p>\n<p>L\u2019\u00e9quipe de Miller\u00a0Thomson qui a conseill\u00e9 les co-chefs de file dans le cadre du financement et de la prise de contr\u00f4le invers\u00e9e \u00e9tait dirig\u00e9e par Lawrence Wilder et compos\u00e9e d\u2019Adam Kline, Ian Polisuk, Connor Broude et Andrea Chiu (droit des soci\u00e9t\u00e9s et f&amp;a).<\/p>\n","protected":false},"author":92,"template":"","class_list":["post-7589","deals-cases","type-deals-cases","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e | Miller Thomson<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e | Miller Thomson\" \/>\n<meta property=\"og:description\" content=\"Conseillers juridiques de Stifel GMP\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\" \/>\n<meta property=\"og:site_name\" content=\"Miller Thomson\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-12T19:26:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@millerthomson\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\",\"name\":\"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e | Miller Thomson\",\"isPartOf\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\"},\"datePublished\":\"2023-06-12T21:19:17+00:00\",\"dateModified\":\"2024-09-12T19:26:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions et mandats\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"description\":\"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.\",\"publisher\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"contentUrl\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"width\":380,\"height\":50,\"caption\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\"},\"image\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\",\"https:\/\/x.com\/millerthomson\",\"https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/\",\"https:\/\/www.youtube.com\/@millerthomson\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e | Miller Thomson","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","og_locale":"fr_FR","og_type":"article","og_title":"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e | Miller Thomson","og_description":"Conseillers juridiques de Stifel GMP","og_url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","og_site_name":"Miller Thomson","article_publisher":"https:\/\/www.facebook.com\/MillerThomsonLaw\/","article_modified_time":"2024-09-12T19:26:30+00:00","twitter_card":"summary_large_image","twitter_site":"@millerthomson","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","name":"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e | Miller Thomson","isPartOf":{"@id":"https:\/\/www.millerthomson.com\/fr\/#website"},"datePublished":"2023-06-12T21:19:17+00:00","dateModified":"2024-09-12T19:26:30+00:00","breadcrumb":{"@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.millerthomson.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Transactions et mandats","item":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/"},{"@type":"ListItem","position":3,"name":"ZYUS Life Sciences conclut un financement par re\u00e7us de souscription avec interm\u00e9diaire et une prise de contr\u00f4le invers\u00e9e"}]},{"@type":"WebSite","@id":"https:\/\/www.millerthomson.com\/fr\/#website","url":"https:\/\/www.millerthomson.com\/fr\/","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","description":"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.","publisher":{"@id":"https:\/\/www.millerthomson.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.millerthomson.com\/fr\/#organization","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","url":"https:\/\/www.millerthomson.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","contentUrl":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","width":380,"height":50,"caption":"Miller Thomson | Cabinet de droit des affaires pancanadien"},"image":{"@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MillerThomsonLaw\/","https:\/\/x.com\/millerthomson","https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/","https:\/\/www.youtube.com\/@millerthomson"]}]}},"_links":{"self":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases"}],"about":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/types\/deals-cases"}],"author":[{"embeddable":true,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/users\/92"}],"version-history":[{"count":0,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7589\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/media?parent=7589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}